CCMI
CYTK icon

Creative Capital Management Investments’s Cytokinetics CYTK Stock Holding History

Creative Capital Management Investments’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$767 Buy
+9
New +$646 ﹤0.01% 1170

Other funds holding CYTK

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Creative Capital Management Investments's CYTK Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Cytokinetics (CYTK) in Q2 2026: 9 shares worth $767. The stake represents ﹤0.01% of the portfolio and ranks #1170 among its holdings.

72 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Creative Capital Management Investments held 9 shares of Cytokinetics worth $767 as of Q2 2026.
  • Cytokinetics was a new Creative Capital Management Investments position in Q2 2026.
  • Cytokinetics made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #1170 holding.
  • 72 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.